Literature DB >> 35361787

SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applications.

Martyna Plens-Gałąska1, Tomasz Woźniak2, Joanna Wesoły3, Hans A R Bluyssen4.   

Abstract

The abnormal activation of signal transducer and activator of transcription (STAT) protein family is recognized as cause or driving force behind multiple diseases progression. Therefore, searching for potential treatment strategy is pursued by multiple scientific groups. We consider that providing comprehensive, integrated and unified dataset for STAT inhibitory compounds may serve as important tool for other researchers. We developed SINBAD (STAT INhbitor Biology And Drug-ability) in response to our experience with inhibitory compound research, knowing that gathering detailed information is crucial for effective experiment design and also for finding potential solutions in case of obtaining inconclusive results. SINBAD is a curated database of STAT inhibitors which have been published and described in scientific articles providing prove of their inhibitory properties. It is a tool allowing easy analysis of experimental conditions and provides detailed information about known STAT inhibitory compounds.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35361787      PMCID: PMC8971479          DOI: 10.1038/s41597-022-01243-3

Source DB:  PubMed          Journal:  Sci Data        ISSN: 2052-4463            Impact factor:   6.444


  19 in total

1.  Identification of a New Series of STAT3 Inhibitors by Virtual Screening.

Authors:  Kenji Matsuno; Yoshiaki Masuda; Yutaka Uehara; Hiroshi Sato; Ayumu Muroya; Osamu Takahashi; Takane Yokotagawa; Toshio Furuya; Tadashi Okawara; Masami Otsuka; Naohisa Ogo; Tadashi Ashizawa; Chie Oshita; Sachiko Tai; Hidee Ishii; Yasuto Akiyama; Akira Asai
Journal:  ACS Med Chem Lett       Date:  2010-07-13       Impact factor: 4.345

2.  A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.

Authors:  Hui Song; Renxiao Wang; Shaomeng Wang; Jiayuh Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

Review 3.  JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.

Authors:  Sangeetha Venugopal; Michal Bar-Natan; John O Mascarenhas
Journal:  Blood Rev       Date:  2019-10-25       Impact factor: 8.250

4.  Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening.

Authors:  L-J Liu; K-H Leung; D S-H Chan; Y-T Wang; D-L Ma; C-H Leung
Journal:  Cell Death Dis       Date:  2014-06-12       Impact factor: 8.469

5.  Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.

Authors:  Malgorzata Szelag; Anna Czerwoniec; Joanna Wesoly; Hans A R Bluyssen
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

Review 6.  The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.

Authors:  Bakiye Goker Bagca; Cigir Biray Avci
Journal:  Cytokine Growth Factor Rev       Date:  2020-06-20       Impact factor: 7.638

Review 7.  Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.

Authors:  Michał Wiciński; Maciej Socha; Maciej Walczak; Eryk Wódkiewicz; Bartosz Malinowski; Sebastian Rewerski; Karol Górski; Katarzyna Pawlak-Osińska
Journal:  Nutrients       Date:  2018-11-21       Impact factor: 5.717

Review 8.  The Immunomodulatory and Anti-Inflammatory Role of Polyphenols.

Authors:  Nour Yahfoufi; Nawal Alsadi; Majed Jambi; Chantal Matar
Journal:  Nutrients       Date:  2018-11-02       Impact factor: 5.717

Review 9.  JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.

Authors:  Farhad Seif; Hossein Aazami; Majid Khoshmirsafa; Monireh Kamali; Monireh Mohsenzadegan; Majid Pornour; Davood Mansouri
Journal:  Int Arch Allergy Immunol       Date:  2020-05-11       Impact factor: 2.749

Review 10.  The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature.

Authors:  Alice Wang; Katelyn Singh; Wael Ibrahim; Brett King; William Damsky
Journal:  Yale J Biol Med       Date:  2020-03-27
View more
  1 in total

Review 1.  Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.

Authors:  Mahdi Eskandarian Boroujeni; Agata Sekrecka; Aleksandra Antonczyk; Sanaz Hassani; Michal Sekrecki; Hanna Nowicka; Natalia Lopacinska; Arta Olya; Katarzyna Kluzek; Joanna Wesoly; Hans A R Bluyssen
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.